vs

Side-by-side financial comparison of B&G Foods, Inc. (BGS) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $439.3M, roughly 1.2× B&G Foods, Inc.). B&G Foods, Inc. runs the higher net margin — -4.4% vs -12.3%, a 8.0% gap on every dollar of revenue. Genius Sports Ltd produced more free cash flow last quarter ($69.6M vs $-70.7M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs -12.8%).

B&G Foods, Inc. is an American branded foods holding company based in Parsippany, New Jersey. The company was formed in 1996 to acquire Bloch & Guggenheimer, a Manhattan-based producer of pickles, relish and condiments which had been founded in 1889.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

BGS vs GENI — Head-to-Head

Bigger by revenue
GENI
GENI
1.2× larger
GENI
$510.9M
$439.3M
BGS
Higher net margin
BGS
BGS
8.0% more per $
BGS
-4.4%
-12.3%
GENI
More free cash flow
GENI
GENI
$140.3M more FCF
GENI
$69.6M
$-70.7M
BGS
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
-12.8%
BGS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BGS
BGS
GENI
GENI
Revenue
$439.3M
$510.9M
Net Profit
$-19.1M
$-63.0M
Gross Margin
22.5%
25.2%
Operating Margin
2.5%
-11.5%
Net Margin
-4.4%
-12.3%
Revenue YoY
-4.7%
Net Profit YoY
-356.5%
EPS (diluted)
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BGS
BGS
GENI
GENI
Q4 25
$510.9M
Q3 25
$439.3M
$335.4M
Q2 25
$424.4M
$215.2M
Q1 25
$425.4M
$119.7M
Q4 24
$551.6M
$413.0M
Q3 24
$461.1M
$285.8M
Q2 24
$444.6M
$184.1M
Q1 24
$475.2M
$97.2M
Net Profit
BGS
BGS
GENI
GENI
Q4 25
$-63.0M
Q3 25
$-19.1M
Q2 25
$-9.8M
$-47.3M
Q1 25
$835.0K
$-25.5M
Q4 24
$-222.4M
$-85.5M
Q3 24
$7.5M
$-47.1M
Q2 24
$3.9M
$-35.5M
Q1 24
$-40.2M
$-25.2M
Gross Margin
BGS
BGS
GENI
GENI
Q4 25
25.2%
Q3 25
22.5%
24.2%
Q2 25
20.5%
19.1%
Q1 25
21.2%
10.7%
Q4 24
21.5%
16.7%
Q3 24
22.2%
20.5%
Q2 24
20.7%
18.6%
Q1 24
22.9%
9.8%
Operating Margin
BGS
BGS
GENI
GENI
Q4 25
-11.5%
Q3 25
2.5%
-15.3%
Q2 25
5.2%
-21.0%
Q1 25
8.4%
-20.3%
Q4 24
-46.6%
-18.0%
Q3 24
11.1%
-13.9%
Q2 24
9.9%
-16.8%
Q1 24
-3.3%
-23.7%
Net Margin
BGS
BGS
GENI
GENI
Q4 25
-12.3%
Q3 25
-4.4%
Q2 25
-2.3%
-22.0%
Q1 25
0.2%
-21.3%
Q4 24
-40.3%
-20.7%
Q3 24
1.6%
-16.5%
Q2 24
0.9%
-19.3%
Q1 24
-8.5%
-25.9%
EPS (diluted)
BGS
BGS
GENI
GENI
Q4 25
Q3 25
$-0.24
Q2 25
$-0.12
Q1 25
$0.01
Q4 24
$-2.81
Q3 24
$0.09
Q2 24
$0.05
Q1 24
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BGS
BGS
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$60.9M
$280.6M
Total DebtLower is stronger
$2.0B
Stockholders' EquityBook value
$470.7M
$724.5M
Total Assets
$2.9B
$1.1B
Debt / EquityLower = less leverage
4.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BGS
BGS
GENI
GENI
Q4 25
$280.6M
Q3 25
$60.9M
$110.2M
Q2 25
$54.1M
$110.2M
Q1 25
$61.2M
$110.2M
Q4 24
$50.6M
$100.3M
Q3 24
$54.7M
$100.3M
Q2 24
$40.3M
$100.3M
Q1 24
$42.5M
$100.3M
Total Debt
BGS
BGS
GENI
GENI
Q4 25
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.1B
Q2 24
$2.0B
Q1 24
$2.0B
Stockholders' Equity
BGS
BGS
GENI
GENI
Q4 25
$724.5M
Q3 25
$470.7M
$572.4M
Q2 25
$501.4M
$572.4M
Q1 25
$513.1M
$572.4M
Q4 24
$524.8M
$573.0M
Q3 24
$755.3M
$573.0M
Q2 24
$765.0M
$573.0M
Q1 24
$781.2M
$573.0M
Total Assets
BGS
BGS
GENI
GENI
Q4 25
$1.1B
Q3 25
$2.9B
$792.3M
Q2 25
$2.9B
$792.3M
Q1 25
$3.0B
$792.3M
Q4 24
$3.0B
$775.7M
Q3 24
$3.4B
$775.7M
Q2 24
$3.4B
$775.7M
Q1 24
$3.4B
$775.7M
Debt / Equity
BGS
BGS
GENI
GENI
Q4 25
Q3 25
4.30×
Q2 25
3.97×
Q1 25
3.91×
Q4 24
3.85×
Q3 24
2.75×
Q2 24
2.67×
Q1 24
2.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BGS
BGS
GENI
GENI
Operating Cash FlowLast quarter
$-64.6M
$81.9M
Free Cash FlowOCF − Capex
$-70.7M
$69.6M
FCF MarginFCF / Revenue
-16.1%
13.6%
Capex IntensityCapex / Revenue
1.4%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$54.8M
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BGS
BGS
GENI
GENI
Q4 25
$81.9M
Q3 25
$-64.6M
$-4.8M
Q2 25
$17.8M
$-1.2M
Q1 25
$52.7M
$-14.6M
Q4 24
$80.3M
$14.9M
Q3 24
$4.2M
$-9.2M
Q2 24
$11.3M
Q1 24
$35.1M
Free Cash Flow
BGS
BGS
GENI
GENI
Q4 25
$69.6M
Q3 25
$-70.7M
$-14.2M
Q2 25
$11.5M
$-5.8M
Q1 25
$42.4M
$-16.0M
Q4 24
$71.7M
$11.3M
Q3 24
$-679.0K
$-11.6M
Q2 24
$5.2M
Q1 24
$27.5M
FCF Margin
BGS
BGS
GENI
GENI
Q4 25
13.6%
Q3 25
-16.1%
-4.2%
Q2 25
2.7%
-2.7%
Q1 25
10.0%
-13.4%
Q4 24
13.0%
2.7%
Q3 24
-0.1%
-4.1%
Q2 24
1.2%
Q1 24
5.8%
Capex Intensity
BGS
BGS
GENI
GENI
Q4 25
2.4%
Q3 25
1.4%
2.8%
Q2 25
1.5%
2.1%
Q1 25
2.4%
1.2%
Q4 24
1.6%
0.9%
Q3 24
1.0%
0.9%
Q2 24
1.4%
Q1 24
1.6%
Cash Conversion
BGS
BGS
GENI
GENI
Q4 25
Q3 25
Q2 25
Q1 25
63.17×
Q4 24
Q3 24
0.56×
Q2 24
2.87×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BGS
BGS

Specialty Segment$150.5M34%
Meals Segment$110.0M25%
Spices And Flavor Solutions Segment$101.4M23%
Frozen And Vegetables Segment$77.4M18%

GENI
GENI

Segment breakdown not available.

Related Comparisons